Fragment / CJC1295 / Ipamorelin 12 mg by Peptide Sciences USA

Brand: Peptide Sciences USA

Substance: HGH Fragment 176-191, CJC1295, Ipamorelin

Action of the Drug

This triple peptide blend combines HGH Fragment 176-191 for fat loss, CJC1295 for extended GH release, and Ipamorelin for recovery and regeneration support.

Use in Sports

Widely studied in bodybuilding for promoting fat reduction, preserving lean muscle, enhancing recovery, and stimulating growth hormone pathways.

Period of Drug Withdrawal

Effects diminish gradually within several days after cessation, depending on dosage, duration, and study design.

Rate of Suppression of Natural Testosterone Production

This peptide combination does not suppress natural testosterone production, making it a versatile tool for advanced peptide research.

What Should Be Used During and After Use

During use:

• Follow structured research protocols
• Track fat loss, recovery rate, and lean mass retention

After use:

• Monitor GH-related markers and tissue recovery response

Combinations with Other Anabolic and Androgenic Drugs

Can be stacked with anabolic compounds or peptides for enhanced fat-burning, muscle retention, and growth hormone amplification in research settings.

Possible Side Effects and How to Avoid Them

• Mild water retention – manage dosage
• Occasional fatigue – ensure proper rest

Why We Recommend It

Fragment / CJC1295 / Ipamorelin provides synergistic benefits for fat loss, GH stimulation, and recovery, making it a powerful research peptide blend.

Comparison with Other Drugs

Unlike single compounds, this trio delivers prolonged GH release, targeted fat reduction, and improved recovery potential.

Main Properties

• Fat Reduction: Fragment 176-191 targets adipose tissue
• Extended GH Release: CJC1295 prolongs growth hormone effects
• Recovery Support: Ipamorelin aids muscle repair
• Non-Suppressive: No testosterone inhibition

Fragment / CJC1295 / Ipamorelin 12 mg by Peptide Sciences USA is a high-quality research peptide blend for fat loss, recovery, and GH-focused studies.